TI
ANTH

Turner Investments’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Turner Investments’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,875
Closed -$10K – 305
2016
Q4 		$10K Buy
+1,875
New +$32.5K ﹤0.01% 257

Other funds holding ANTH

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Turner Investments's ANTH Position: Q1 2017 in Review

Turner Investments sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q1 2017, closing a stake of 1,875 shares — an estimated $10K sold.

Turner Investments first reported a position in ANTH in Q4 2016 and held it in 1 quarter. The position peaked at $10K in Q4 2016. 60 funds tracked by Wall St. Rank hold ANTH as of Q1 2017.

  • Turner Investments reported no remaining Anthera Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Turner Investments sold 1,875 Anthera Pharmaceuticals, Inc. shares in Q1 2017, an estimated $10K.
  • Turner Investments first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2016 and held it in 1 quarter.
  • Turner Investments's Anthera Pharmaceuticals, Inc. position peaked at $10K in Q4 2016.
  • 60 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q1 2017.

Based on Turner Investments's 13F filing for Q1 2017, filed 11 May 2017.